Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single-cell RNA profiling of oligodendroglial lineage cells derived from iPSCs carrying Parkinson's disease-relevant LRRK2-G2019S mutation.

iScience·2026

Same author

Correction: Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis.

Journal of neuroinflammation·2026

Same author

In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.

Science translational medicine·2026

Same author

Development of a Human Preclinical Platform for the Identification of Neuroprotective Compounds.

The European journal of neuroscience·2025

Same author

White matter degeneration precedes tau aggregation in rats with Alzheimer's-like tauopathy.

Neurobiology of disease·2025

Same author

Alpha synuclein-mediated cytoskeletal dysfunction impairs myelination in human oligodendrocytes.

Acta neuropathologica·2025

Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026

Same journal

Editorial introduction.

Current opinion in neurology·2026

Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026

Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026

Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026

Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 5, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

New insights in multiple sclerosis pathology.

Yotam Menuchin-Lasowski¹, Tanja Kuhlmann

¹Institute of Neuropathology, University Hospital Münster, Münster, Germany.

Current Opinion in Neurology

|April 4, 2026

Summary

This summary is machine-generated.

Tissue-resident memory cells and microglia drive multiple sclerosis (MS) progression by causing central nervous system (CNS) inflammation. Understanding these cellular and molecular mechanisms in MS tissue offers new therapeutic targets for neurodegeneration and remyelination.

Keywords:

microglia neurodegeneration neuropathology remyelination snRNA sequencing spatial transcriptomics tissue memory cells

More Related Videos

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Related Experiment Videos

Last Updated: Apr 5, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Area of Science:

Neuroimmunology
Neurodegeneration
Multiple Sclerosis Pathogenesis

Background:

Multiple sclerosis (MS) disability is linked to relapse-associated worsening and progression independent of relapse activity.
Identifying cellular and molecular drivers of MS progression is crucial for developing effective treatments.

Purpose of the Study:

To review recent studies on the cellular and molecular mechanisms of MS disease progression.
To focus on research utilizing human tissue samples for mechanistic insights.

Main Methods:

Review of current literature on MS progression mechanisms.
Emphasis on studies analyzing human multiple sclerosis tissue samples.
Integration of findings from experimental and human tissue studies, including omics approaches.

Main Results:

Tissue-resident memory cells and microglia are key drivers of persistent CNS inflammation and MS progression.
Soluble factors significantly impact neuronal health, synaptic function, and remyelination.
Interferon-gamma triggers detrimental neuronal injury mechanisms.
Omics analyses of MS tissues reveal complex immune cell and neural interactions.

Conclusions:

Recent advancements have significantly improved understanding of MS progression mechanisms.
Modern omics analyses of MS tissues offer deep insights into disease pathways.
These findings may lead to novel therapeutic strategies targeting CNS inflammation, neurodegeneration, and remyelination.